Iconovo AB (publ)
ICO
Rank in Stocks
#28547
Based in Lund, Sweden, Iconovo AB (publ) focuses on the creation and licensing... Based in Lund, Sweden, Iconovo AB (publ) focuses on the creation and licensing of advanced inhalation delivery systems. Their product portfolio encompasses a variety of dry powder inhalers, such as the versatile multi-dose ICOres, the capsule-driven ICOcap, the single-use disposable ICOone, and the pre-metered ICOpre. Beyond these standard devices, the company also designs custom inhalation solutions, primarily catering to generic pharmaceutical firms. Iconovo is involved in significant collaborative ventures, including a project with Immune System Regulation AB to develop an inhaled COVID-19 vaccine using their ICOone inhaler, and a partnership with Respiratorius AB (publ) to formulate an inhalation treatment for COPD. The company was established in 2013.
Share Price
$0.11171862
Last synced: 2026-11-09
Market Cap
$10.74M
Change (1 day)
5.24%
Change (1 year)
-39.27%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Iconovo AB (publ) (ICO)
Category
Healthcare
EPS for Iconovo AB (publ) (ICO)
EPS as of September 2026 TTM: $-0.05
According to Iconovo AB (publ)'s latest financial reports, its current EPS (TTM) is $-0.05. At the end of 2025 the company had an EPS of $-0.12, an increase over its 2024 EPS of $-0.23.
EPS history for Iconovo AB (publ) from 2015 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.05 | -57.08% |
| 2025 | $-0.12 | -47.00% |
| 2024 | $-0.23 | -46.46% |
| 2023 | $-0.44 | -20.25% |
| 2022 | $-0.55 | 56.77% |
| 2021 | $-0.35 | 30.77% |
| 2020 | $-0.27 | 53.43% |
| 2019 | $-0.17 | 134.78% |
| 2018 | $-0.07 | -323.94% |
| 2017 | $0.03 | -30.23% |
| 2016 | $0.05 | -105.36% |
| 2015 | $-0.88 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -5,342.72% |
US
|
|
| $4.09 | -8,041.75% |
IE
|
|
| $9.45 | -18,449.51% |
US
|
|
| $2.37 | -4,701.94% |
US
|
|
| $1.77 | -3,536.89% |
US
|
Questions about Iconovo AB (publ)'s earnings per share (EPS)
What is Iconovo AB (publ)'s earnings per share (EPS)?
Iconovo AB (publ)'s earnings per share (EPS) over the last twelve months is $-0.05, as of Sep 2026.
What was Iconovo AB (publ)'s earnings per share (EPS) in 2025?
In 2025, Iconovo AB (publ)'s earnings per share (EPS) was $-0.12, compared with $-0.23 in 2024.
How has Iconovo AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Iconovo AB (publ)'s earnings per share (EPS) was highest in 2025 ($-0.12) and lowest in 2022 ($-0.55).
How does Iconovo AB (publ)'s earnings per share (EPS) compare with similar companies?
Iconovo AB (publ)'s earnings per share (EPS) ($-0.05) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.